Longitudinal analysis of the salivary metabolome of breast-fed and formula-fed infants over the first year of life.


Journal

Metabolomics : Official journal of the Metabolomic Society
ISSN: 1573-3890
Titre abrégé: Metabolomics
Pays: United States
ID NLM: 101274889

Informations de publication

Date de publication:
11 03 2020
Historique:
received: 19 09 2019
accepted: 05 03 2020
entrez: 13 3 2020
pubmed: 13 3 2020
medline: 22 12 2020
Statut: epublish

Résumé

The salivary metabolome has been increasingly studied over the past ten years due to the potential of saliva as a non-invasive source of biomarkers. However, although saliva has been studied in relation to various diseases, its dynamic evolution during life is not known. This is particularly true for the first months of life. Infancy is indeed a critical period during which numerous behavioural and physiological events occur, such as dietary transitions and tooth eruption, which can lead to important biological modifications in the oral cavity. The aim of this work was therefore to study the evolution of the salivary metabolome during the first months of life by Saliva of 32 infants with different milk feeding histories (breast vs formula) was collected at 6 stages, including 3 months old, 15 days before the onset of complementary feeding (CF), approximately 15 days after the onset of CF, approximately 21 days after the onset of CF and at approximately 11 and 15 months, and analysed. The longitudinal analysis showed a significant modification of the profiles of 18 metabolites over time; 14 presented an increase in abundance whereas 4 presented a decrease. These modifications seemed to be linked, for the most part, to an increase in oral microbial metabolism. Milk feeding history during the first months of life had no effect on metabolites. This work shows that the salivary metabolome should be considered when studying the changes occurring during infancy.

Identifiants

pubmed: 32162105
doi: 10.1007/s11306-020-01661-7
pii: 10.1007/s11306-020-01661-7
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

37

Références

Mol Oral Microbiol. 2018 Feb;33(1):38-46
pubmed: 28776953
Am J Clin Nutr. 1984 Apr;39(4):584-8
pubmed: 6608871
Physiol Behav. 2017 May 1;173:116-123
pubmed: 28185876
Nutr Res Rev. 2010 Jun;23(1):23-36
pubmed: 20450531
Bull World Health Organ. 1997;75(3):261-90
pubmed: 9277014
Appetite. 2018 Dec 1;131:160-168
pubmed: 30172680
Am J Clin Nutr. 2019 May 1;109(5):1344-1352
pubmed: 30997507
J Periodontol. 2018 Dec;89(12):1452-1460
pubmed: 29877582
Sci Rep. 2018 Oct 11;8(1):15112
pubmed: 30310099
Bioinformatics. 2005 Jul 1;21(13):3043-8
pubmed: 15890747
Arch Oral Biol. 1987;32(9):607-10
pubmed: 3481959
Arch Oral Biol. 2014 Jan;59(1):1-11
pubmed: 24246267
Exp Biol Med (Maywood). 2017 Mar;242(5):459-472
pubmed: 27903834
Pharmacol Res. 2013 Mar;69(1):137-43
pubmed: 23201354
J Proteome Res. 2015 Apr 3;14(4):1666-77
pubmed: 25761918
ISME J. 2018 Sep;12(9):2292-2306
pubmed: 29899505
PLoS One. 2015 Sep 04;10(9):e0137473
pubmed: 26340090
Oral Dis. 2002 Jan;8(1):12-22
pubmed: 11936451
J Proteomics. 2015 Oct 14;128:105-12
pubmed: 26232109
Oral Dis. 2019 Jan;25(1):16-25
pubmed: 29750386
Appl Environ Microbiol. 2014 Jun;80(11):3416-25
pubmed: 24657864
Mol Cell Proteomics. 2011 Jan;10(1):M110.003467
pubmed: 20943598
J Proteome Res. 2016 Aug 5;15(8):2491-9
pubmed: 27306956
J Texture Stud. 2019 Feb;50(1):19-26
pubmed: 30226267
Biomed Res Int. 2018 Jun 14;2018:2838052
pubmed: 30013981
J Pediatr Gastroenterol Nutr. 2013 Feb;56(2):127-36
pubmed: 22955450
Nutr Rev. 2009 Nov;67(11):615-23
pubmed: 19906248
Eur J Nutr. 2020 Feb;59(1):67-80
pubmed: 30648220
PLoS One. 2015 Oct 30;10(10):e0141698
pubmed: 26517871
J Proteomics. 2012 Jun 27;75(12):3665-73
pubmed: 22575268
Crit Rev Oral Biol Med. 2002;13(6):485-508
pubmed: 12499242
Microb Ecol. 2017 Feb;73(2):492-503
pubmed: 27628595
Oral Microbiol Immunol. 2003 Apr;18(2):72-8
pubmed: 12654094
J Gen Microbiol. 1977 Mar;99(1):139-55
pubmed: 405455
BMC Bioinformatics. 2007 Aug 30;8:322
pubmed: 17760983
Sci Rep. 2016 Dec 06;6:38309
pubmed: 27922070
Oral Microbiol Immunol. 1993 Feb;8(1):1-4
pubmed: 8510978
Anal Bioanal Chem. 2005 Mar;381(6):1289-93
pubmed: 15756600
PLoS One. 2015 Sep 01;10(9):e0135047
pubmed: 26325665
Arch Oral Biol. 2011 Jul;56(7):634-42
pubmed: 21429473

Auteurs

Eric Neyraud (E)

Centre des Sciences du Goût et de l'alimentation, AgroSup Dijon, CNRS, INRAE, Université de Bourgogne Franche-Comté, 17 rue Sully, 21000, Dijon, France. eric.neyraud@inrae.fr.

Camille Schwartz (C)

Centre des Sciences du Goût et de l'alimentation, AgroSup Dijon, CNRS, INRAE, Université de Bourgogne Franche-Comté, 17 rue Sully, 21000, Dijon, France.

Hélène Brignot (H)

Centre des Sciences du Goût et de l'alimentation, AgroSup Dijon, CNRS, INRAE, Université de Bourgogne Franche-Comté, 17 rue Sully, 21000, Dijon, France.

Isabelle Jouanin (I)

Toxalim (Research Centre in Food Toxicology), INRAE, ENVT, INP-Purpan, UPS, Université de Toulouse, 31027, Toulouse, France.
Axiom Platform, MetaToul-MetaboHub, National Infrastructure for Metabolomics and Fluxomics, 31027, Toulouse, France.

Marie Tremblay-Franco (M)

Toxalim (Research Centre in Food Toxicology), INRAE, ENVT, INP-Purpan, UPS, Université de Toulouse, 31027, Toulouse, France.
Axiom Platform, MetaToul-MetaboHub, National Infrastructure for Metabolomics and Fluxomics, 31027, Toulouse, France.

Cécile Canlet (C)

Toxalim (Research Centre in Food Toxicology), INRAE, ENVT, INP-Purpan, UPS, Université de Toulouse, 31027, Toulouse, France.
Axiom Platform, MetaToul-MetaboHub, National Infrastructure for Metabolomics and Fluxomics, 31027, Toulouse, France.

Carole Tournier (C)

Centre des Sciences du Goût et de l'alimentation, AgroSup Dijon, CNRS, INRAE, Université de Bourgogne Franche-Comté, 17 rue Sully, 21000, Dijon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH